Apollon Wealth Management’s TuHURA Biosciences HURA Stock Holding History
Bought
Maintained
Sold
Other funds holding HURA
VCM
VFT
VPM
Apollon Wealth Management's HURA Position: Q1 2026 in Review
Apollon Wealth Management increased its TuHURA Biosciences (HURA) stake by 18% in Q1 2026, buying an estimated $29.1K and bringing the position to 158,010 shares worth $283K. The position accounts for ﹤0.01% of the portfolio, ranked #1151.
Apollon Wealth Management first reported a position in HURA in Q4 2024 and has held it in 6 quarters since. The position peaked at $371K in Q1 2025. 89 funds tracked by Wall St. Rank hold HURA as of Q1 2026.
- Apollon Wealth Management held 158,010 shares of TuHURA Biosciences worth $283K as of Q1 2026.
- Apollon Wealth Management bought 23,717 TuHURA Biosciences shares in Q1 2026, an estimated $29.1K.
- TuHURA Biosciences made up ﹤0.01% of Apollon Wealth Management's portfolio in Q1 2026, its #1151 holding.
- Apollon Wealth Management first reported a position in TuHURA Biosciences in Q4 2024 and has held it in 6 quarters since.
- Apollon Wealth Management's TuHURA Biosciences position peaked at $371K in Q1 2025.
- 89 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q1 2026.
Based on Apollon Wealth Management's 13F filing for Q1 2026, filed 22 Apr 2026.